Northcape Wealth Management LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,353 shares of the company’s stock, valued at approximately $1,073,000.
A number of other large investors have also recently made changes to their positions in MKGAF. Addison Advisors LLC bought a new position in shares of Merck KGaA in the 2nd quarter valued at about $90,000. Comprehensive Financial Planning Inc. PA bought a new stake in Merck KGaA during the second quarter worth approximately $134,000. Stevens Capital Partners bought a new stake in Merck KGaA during the second quarter worth approximately $220,000. United Bank purchased a new stake in Merck KGaA during the second quarter valued at approximately $248,000. Finally, CM Wealth Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at approximately $334,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Price Performance
OTCMKTS:MKGAF opened at $167.38 on Thursday. The firm has a market capitalization of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The business has a 50 day simple moving average of $162.50 and a 200-day simple moving average of $148.28. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
